Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study

The Lancet Oncology 2026

View at publisher
Authors: Shankar Siva, David Pryor, Jarad Martin, Nicholas Hardcastle, Daniel Moon, Tomas Kron, Braden Higgs, Farshad Foroudi, Jeremy Ruben, Swetha Sridharan, Rebecca Montgomery, Ryan Davey
+16 more Charles Lin, Mark Shaw, Nathan Lawrentschuk, Sree Appu, Ben G L Vanneste, Michael S Hofman, Declan G Murphy, Richard De Abreu Lourenco, Pascal Mancuso, Nicholas R. Brook, Avi Raman, Lih‐Ming Wong, Mark Sidhom, Simon Wood, Muhammad Ali, Mathias Bressel
DOI: 10.1016/s1470-2045(26)00091-4
Cited by: 5
References: 28

Fields of Study & Subjects

Renal cell carcinoma treatment Hepatocellular Carcinoma Treatment and Prognosis Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
6
Pages
711–720
Publication date
17 May 2026
Language
EN